Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01091376
What this trial is testing

Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06475755
What this trial is testing

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

Who this might be right for
Non-Small Cell Lung CancerAnti Angiogenesis
Tang-Du Hospital 178
Testing effectiveness (Phase 2)Ended earlyNCT04560686
What this trial is testing

Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+8 more
M.D. Anderson Cancer Center 2
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Testing effectiveness (Phase 2)Looking for participantsNCT07586202
What this trial is testing

Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT05714891
What this trial is testing

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Canadian Cancer Trials Group 4
Testing effectiveness (Phase 2)Looking for participantsNCT07229729
What this trial is testing

SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 300
Not applicableLooking for participantsNCT04324151
What this trial is testing

Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 70
Large-scale testing (Phase 3)Looking for participantsNCT04316364
What this trial is testing

A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 537
Not applicableLooking for participantsNCT06634199
What this trial is testing

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer Stage IIIPDL1 Gene Mutation
Fundación GECP 50
Testing effectiveness (Phase 2)Study completedNCT00248495
What this trial is testing

Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06998719
What this trial is testing

Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBorderline Resectable Carcinoma
Bi Nan 80
Testing effectiveness (Phase 2)Study completedNCT02716038
What this trial is testing

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Columbia University 39
Large-scale testing (Phase 3)Ended earlyNCT00480025
What this trial is testing

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 2,278
Not applicableStudy completedNCT00341380
What this trial is testing

Prevention of Tumor Spread Due to Lung Cancer Surgery

Who this might be right for
Non-Small Cell Lung Cancer
National Institute of Environmental Health Sciences (NIEHS) 41
Testing effectiveness (Phase 2)UnknownNCT04338620
What this trial is testing

Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC

Who this might be right for
Non-small-cell Lung Cancer (NSCLC)
Tang-Du Hospital 94
Testing effectiveness (Phase 2)Study completedNCT00463515
What this trial is testing

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

Who this might be right for
Non-Small-Cell-Lung Cancer
University Hospital, Antwerp 77
Testing effectiveness (Phase 2)WithdrawnNCT01679743
What this trial is testing

GRN1005 for Brain Metastases From Breast or Lung Cancer

Who this might be right for
Breast CancerLung NeoplasmsBreast Neoplasms+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06269211
What this trial is testing

Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ruijin Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT06917573
What this trial is testing

PALACE: Cemiplimab Trial According to ctDNA Levels

Who this might be right for
Non Small Cell Lung Cancer MetastaticLung DiseasesStage IV Non-small Cell Lung Cancer+3 more
Fundación GECP 63
Next Page